Towa Pharmaceutical Co Stock Net Income
| TWAPFDelisted Stock | USD 16.83 0.00 0.00% |
Fundamental analysis of Towa Pharmaceutical allows traders to better anticipate movements in Towa Pharmaceutical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Towa |
Towa Pharmaceutical Co Company Net Income Analysis
Towa Pharmaceutical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Towa Pharmaceutical Net Income | 16.95 B |
Most of Towa Pharmaceutical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Towa Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Towa Pharmaceutical Co reported net income of 16.95 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is significantly lower than that of the firm.
Towa Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Towa Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Towa Pharmaceutical could also be used in its relative valuation, which is a method of valuing Towa Pharmaceutical by comparing valuation metrics of similar companies.Towa Pharmaceutical is currently under evaluation in net income category among its peers.
Towa Fundamentals
| Return On Equity | 14.4 | |||
| Return On Asset | 5.47 | |||
| Profit Margin | 10.43 % | |||
| Operating Margin | 13.20 % | |||
| Current Valuation | 56.49 B | |||
| Shares Outstanding | 49.21 M | |||
| Shares Owned By Insiders | 47.82 % | |||
| Shares Owned By Institutions | 16.46 % | |||
| Price To Earning | 8.48 X | |||
| Price To Book | 0.01 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 162.51 B | |||
| Gross Profit | 65.45 B | |||
| EBITDA | 31.73 B | |||
| Net Income | 16.95 B | |||
| Cash And Equivalents | 24.39 B | |||
| Cash Per Share | 495.57 X | |||
| Total Debt | 79.68 B | |||
| Debt To Equity | 0.63 % | |||
| Current Ratio | 2.49 X | |||
| Cash Flow From Operations | 20.79 B | |||
| Earnings Per Share | 2.87 X | |||
| Number Of Employees | 3.46 K | |||
| Beta | 0.24 | |||
| Market Capitalization | 1.26 B | |||
| Last Dividend Paid | 0.44 |
About Towa Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Towa Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Towa Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Towa Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Towa Pink Sheet
If you are still planning to invest in Towa Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Towa Pharmaceutical's history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |